5 Minutes with Carole Renouf
29 February 2016
What are you most excited about as you look towards leading MIA into the future?
Leadership for me is all about the fulfilment of potential. That’s my job – to help an organisation and its people achieve their greatest potential. I am excited about the wealth of potential at MIA. This is an organisation that, in the medical and scientific world, has already established a stellar reputation. Now it’s time to share that with other worlds, and invite them to be part of it and support it.
Why did you want to work with MIA and what are you hoping to achieve through your work?
Somehow, health and medical research has turned out to be my ‘space’. I think it’s because I believe health is our greatest asset. People with health problems –whatever these are - need the best possible treatments and care today, but they also need the promise that research brings – a better tomorrow. MIA is quite a unique organisation in that it brings together, on a daily basis, care and research for the betterment of people with melanoma and to prevent others getting melanoma. If together we can achieve those goals, I will be happy.
Where did you work before coming to MIA?
Before joining MIA, I worked at St Vincent’s, the National Breast Cancer Foundation and the Garvan Institute. I have always worked in the not for profit sector, although it was originally an unconscious rather than a conscious choice. I am interested in social change, so it’s a natural fit despite the many challenges – especially lack of resources.
What drives you as a CEO?
I don’t think leaders are born. I think they are made, and that they are made through confident humility and an openness to lifelong learning. I guess that defines me as a CEO.
It’s interesting to me that today, the ‘soft’ skills which I possess are now the ones that are most sought-after in CEOs. I always used to feel inadequate because the ‘hard’ skills (say, accounting or operations) were not my strengths. It feels good to know that the world has now caught up with the fact that the ability to inspire, unite, communicate and advocate counts!
What do you like to do in your spare time?
I live a very low key life outside of work. I am actually an introvert in an extrovert’s role, so I burn an enormous amount of energy at work. In my spare time I really need down time with no people around me and preferably outside enjoying nature. I love my daughter. I love the sea. I love animals. I love physical activity. I love travel (definitely not the journey but the destination). And I love reading, preferably crime fiction where every problem gets solved – unlike the real world!
Tell us something most people are surprised to learn about you?
I initiated and ran Australia’s first consensus conference. This is a fascinating Scandinavian method of equipping lay people to give informed advice to Governments about controversial issues in science, technology, education and more. It has often led to great changes in society and I am very proud to have introduced this methodology to Australia.
Melanoma breakthrough paves way for personalised treatment for all cancer patients
Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.
Melanoma March announces 2019 Principal Partner
Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!
Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma
World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
MIA experts collaborate on groundbreaking research
MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.
World-leading pathologist Associate Professor Michael Tetzlaff visits MIA
MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.
Possible PBS listing for dabrafenib and trametinib
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.
Arden Anglican School wins SunSafe Ambassador competition
Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award.
DON'T CLOUD THE SUN-SAFE MESSAGE
Mark Whittaker’s ‘Here comes the sun; Defending our summer rays’ (GW 24 Nov) clouds the sun-safe message – which could have disastrous consequences.
Professor Georgina Long named as one of world's most highly cited researchers
Professor Georgina Long is among only 12 researchers from the University of Sydney to be named in the 2018 Highly Cited Researchers List.
Aussies need to protect themselves from 'everyday' sun damage
‘Wearing sunscreen should be as automatic as wearing a seatbelt. Both are potential life savers.’
The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma
A prestigious $10 million Australian Cancer Research Foundation grant has been awarded to ACEMID, an initiative that aims to use 3D total-body imaging and a remote medicine network to improve the detection and diagnosis of early-stage melanoma.
Major award for world-leaders in melanoma research
Professor Georgina Long and Professor Richard Scolyer have been recognised as world leaders in melanoma research for their ground-breaking work that has changed the diagnosis and treatment landscape of melanoma world-wide, and tripled the life-expectancy of advanced melanoma patients.
Melanoma Institute Australia shines at prestigious Cancer Research Awards
Leading researchers from Melanoma Institute Australia have taken out the top accolades at the NSW Premier’s Awards for Outstanding Cancer Research.
Women of MIA lead the way in melanoma research at SMR
An impressive contingent of female delegates from Melanoma Institute Australia have presented findings across the whole spectrum of melanoma research at the Society for Melanoma Research 2018 Congress in Manchester, England.
Immune cell research presented at SMR
Over 800 researchers and clinicians from around the world were welcomed to Manchester for the 15th International Congress of the Society for Melanoma Research (SMR). Melanoma Institute Australia (MIA) has again sent an impressive number of delegates to present both oral presentations and posters with the latest in translational research.
Professor Georgina Long makes history as the first woman and first Australian to lead the Society for Melanoma Research
Professor Georgina Long makes history as the first woman and first Australian to lead the world’s most prestigious international melanoma research association.
Patients to benefit from updated skin tumour publications
Two publications co-edited by MIA Co-Medical Director Professor Richard Scolyer are now available to healthcare professionals. They aim to provide assistance in the care and management of patients with skin cancer, including melanoma.
SunSafe Student Ambassador Program
Melanoma Institute Australia has introduced a new educational program to teach teenagers about the dangers of melanoma and the importance of sun safety.
International collaboration the key to increasing survival
"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.
High-risk Stage III melanoma patients to benefit from Australia/Netherlands collaboration
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.